Clinical Trials in Houston

Showing 4521-4540 of 17,885 trials

Radiofrequency Ablation of Atrial Fibrillation Under Apnea

NCT04170894

This study seeks to assess the effect of apnea (breath hold) during atrial fibrillation (AF) ablation by having all ablations performed under apnea. By prospectively studying the effects of apnea on AF ablation, the investigators wish to demonstrate its feasibility, safety and impact on patient outcomes. This is a prospective study that includes both an apnea arm and a control arm. The subjects who consent to the apnea arm will undergo an atrial fibrillation ablation with periods of apnea. The subjects who consent to the control arm will agree to have their data from their standard of care atrial fibrillation be collected for comparison.

Atrial Fibrillation

Weill Medical College of Cornell University128 participantsStarted Oct 2020

Bay Shore, New York, United States • Manhasset, New York, United States • New York, New York, United States +3 more locations

Active Not RecruitingPhase 3< 1 mile

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

NCT04951219

A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resmetirom (MGL-3196)

Non-Alcoholic Fatty Liver Disease

Madrigal Pharmaceuticals, Inc.1,000 participantsStarted Jul 2021

Birmingham, Alabama, United States • Chandler, Arizona, United States • Chandler, Arizona, United States +68 more locations

Radiofrequency Ablation of Atrial Fibrillation Under Apnea

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Find Trials by Condition in Houston

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Portico Next Generation Approval Study

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

MYTHS - MYocarditis THerapy With Steroids

DCM Precision Medicine Study

Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Topical Ruxolitinib Evaluation in Chronic Hand Eczema

Optisure Lead Post Approval Study

A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices

A Study in Adults and Adolescents With Angelman Syndrome (STARS)

A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

MGC018 With or Without MGA012 in Advanced Solid Tumors

Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)